Compound Ventures invests in Halcyon Health

NEW YORK, NY, February 4, 2020 — Dentons Venture Technology and Emerging Growth practice advised Compound Ventures, a New York-based venture capital fund that invests in startup and early-stage technology companies, in Halcyon Health’s Series Seed Preferred Stock fundraising round. Partner James Jasaitis led the Dentons team advising Compound Ventures on the transaction.